Oncology Institute (DFPH) EBITDA Margin Growth (1y) (2022 - 2026)
Oncology Institute (DFPH) EBITDA Margin Growth (1y) (2022 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 88.19 Bn | 90.61 Bn | 15.19 Bn | -519.00 |
| 2 | Tenet Healthcare | 21.59 Bn | 21.56 Bn | 4.45 Bn | 1,106.00 |
| 3 | Encompass Health | 12.19 Bn | 12.86 Bn | 1.34 Bn | -101.00 |
| 4 | Davita | 11.52 Bn | 12.39 Bn | 1.16 Bn | 38.00 |
| 5 | Ensign | 10.59 Bn | 10.27 Bn | 306.24 Mn | 4.00 |
| 6 | Universal Health Services | 8.79 Bn | 8.72 Bn | 3.29 Bn | -54.00 |
| 7 | Pacs | 7.04 Bn | 6.88 Bn | 338.46 Mn | 151.00 |
| 8 | Chemed | 6.96 Bn | 6.92 Bn | 221.47 Mn | 225.00 |
| 9 | Concentra Group Holdings Parent | 4.52 Bn | 4.38 Bn | 192.10 Mn | 273.00 |
| 10 | Oncology Institute | 201.94 Mn | 160.85 Mn | 27.17 Mn | 650.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 650.00 |
| Mar 31, 2026 | 508.00 |
| Dec 31, 2025 | 703.00 |
| Sep 30, 2025 | 797.00 |
| Jun 30, 2025 | 724.00 |
| Mar 31, 2025 | 949.00 |
| Dec 31, 2024 | 592.00 |
| Sep 30, 2024 | 311.00 |
| Jun 30, 2024 | 202.00 |
| Mar 31, 2024 | 2,415.00 |
| Dec 31, 2023 | 1,729.00 |
| Sep 30, 2023 | 1,395.00 |
| Jun 30, 2023 | 1,143.00 |
| Mar 31, 2023 | -965.00 |
| Dec 31, 2022 | 4,295.00 |
| Sep 30, 2022 | -2,680.00 |
| Jun 30, 2022 | -2,781.00 |
| Mar 31, 2022 | -2,988.00 |